ProMetic
-
ProMetic to acquire Winnipeg plasma collection centre
Adds to vertical integration of the manufacturing platform.
-
ProMetic extends its reach in Asian markets with $21M deal
R&D project will expand Shenzhen Hepalink’s product line and diversification efforts.
-
ProMetic turns loss around in Q2
Doubles revenues, records a profit of $800,000
-
ProMetic, NantPharma form US biopharmaceutical company
NantPro will manufacture plasma-derived product for US market.
-
ProMetic and Hematech close $10M orphan drug deal
ProMetic Life Sciences Inc. in Laval, Que. has signed a $10-million strategic manufacturing and licence deal with a drug manufacturer in Taiwan to co-develop and commercialize a pharma product that targets a rare medical condition (orphan).
